Endoscopic ultrasound of the pancreas — what the EUS-FNA biopsy involves

The pancreas is one of the hardest organs in the body to sample. It sits deep in the upper abdomen, tucked behind the stomach and wrapped around the large vessels that supply the liver, the bowel and the spleen. A lump in the breast or the neck can be reached with a needle in a few minutes. A mass in the pancreas cannot, and that single fact explains why this test exists.

Endoscopic ultrasound gets around the problem by approaching from the inside. A flexible endoscope with an ultrasound probe built into its tip is passed through the mouth, down the gullet and into the stomach and duodenum — which happen to lie directly against the pancreas. From there the probe is only millimetres from the gland, with no fat, gas or bowel in the way. The pictures it produces are the closest view of the pancreas available in medicine, and they routinely show detail a scanner working from outside the body cannot resolve.

Request forms and referral letters write it in several ways — endoscopic ultrasound pancreas, EUS pancreas biopsy, EUS FNA pancreatic, or simply EUS. They all describe the same appointment. FNA stands for fine needle aspiration, drawing cells out through a very fine needle; FNB, fine needle biopsy, uses a slightly different needle designed to keep a small core of tissue intact. Which one is used depends on what the pathologist needs, and both are done through the same scope in the same sitting.

So the appointment does two jobs at once. First it looks: the probe maps the mass, its size, its edges, the lymph nodes around it and its relationship to the vessels behind the pancreas. Then, if tissue is needed, a needle is passed down a channel in the scope, through the wall of the stomach or duodenum and into the lesion, with the ultrasound showing the needle tip in real time throughout. Nothing is cut on the outside of your body. There is no scar.

One thing is worth saying plainly at the outset. CION does not perform this procedure in-house. Endoscopic ultrasound and the EUS-FNA biopsy taken during it are carried out by specialist gastroenterology and endoscopy partner centres, and that part of your care may be billed by them rather than by us. What we do is decide whether you need it, arrange it, and then act on what it finds.

A positive sample is definitive in one direction: if malignant cells are identified, that is the diagnosis, and the plan can be built on it. A sample that comes back negative, atypical or simply inadequate is a different matter, and this is where people are most often misled by their own relief.

The pancreas is a difficult gland to sample. A mass is frequently surrounded by dense scar-like tissue, and a needle can pass through the right area and still return cells that are inflamed rather than cancerous. A negative result therefore means one thing only: this pass, on this day, did not capture diagnostic cells. It is not an all-clear. Where the imaging and the clinical picture still point towards a tumour, the correct response is to repeat the sampling or take the case to a tumour board — not to send you home reassured.

That cuts both ways. A suspicious scan is not a diagnosis either, and a proportion of pancreatic masses turn out to be chronic inflammation or another benign process once tissue is finally seen. This is exactly why the report is never read on its own: it is read next to the CT, the bloods including CA 19-9 where it is being used, your symptoms and the way the picture has changed over time. Where a general explanation of biopsies and what pathologists do with them would help, our guide to biopsy for cancer diagnosis covers that ground across all cancer types.

• A clear statement of whether diagnostic material was obtained at all, before anything else in the report is weighed.
• What the cells are, and how well differentiated they look — not simply the word positive or negative.
• Whether enough tissue remains in the block for further marker testing, so you are not sent back for a second procedure later.
• Whether any lymph node sampled at the same sitting was involved.
• A named plan for what happens if the sample is inconclusive, agreed before you leave the clinic rather than after weeks of waiting.

1. 1

   The decision is made at CION

   Your oncologist works out whether tissue is genuinely needed now, and by which route, using your scans and the plan being considered. If an operation is going ahead on imaging alone, we will tell you the biopsy can wait rather than add a procedure to your week.

   In-house at CION
2. 2

   The procedure is booked at a partner centre

   An EUS needs an endoscopy suite, a trained endoscopist and anaesthetic cover. CION does not run one, and we would rather say so than blur it. We arrange the appointment with a specialist gastroenterology or endoscopy partner, and that part of your care is billed there.

   Coordinated with a partner endoscopy centre
3. 3

   Preparation is confirmed with you

   You will be asked not to eat for several hours beforehand. Blood-thinning medication, diabetes treatment and any heart or lung condition are reviewed in advance. Because you will be sedated, someone needs to travel home with you, and you should not drive that day.

   Coordinated with a partner endoscopy centre
4. 4

   The procedure itself

   You are sedated, so you are not aware of it and will not remember it. The scope goes in through the mouth, the pancreas is examined, and needle passes are taken if tissue is required. The examination usually takes well under an hour, and nothing is cut on the outside of your body.

   Coordinated with a partner endoscopy centre
5. 5

   The sample goes to pathology

   Some centres check the adequacy of the sample on the spot, with a pathologist in the room, which reduces the chance of being called back. The full report, including any marker testing, takes longer than the procedure did and is the part worth waiting for properly.

   Coordinated with a partner endoscopy centre
6. 6

   The report comes back to your oncologist

   We read it against your CT, your bloods and the clinical picture, and take the case to a tumour board rather than acting on one line of a report. Where it is definite, the plan set out in pancreatic cancer treatment in Hyderabad starts from there.

   In-house at CION
7. 7

   What it means is explained to you in person

   You get the finding, what it changes, what it does not change, and the next step, in plain language and written down. If the sample was inconclusive, you are told that plainly too, along with what we intend to do about it and when.

   In-house at CION

Most people go home the same day. The sedation wears off over a few hours, and it is normal to feel groggy, to have a mildly sore throat and to feel bloated from the air used during the examination. Eating usually restarts once you are fully awake and swallowing comfortably. Plan on doing nothing much for the rest of the day, and on someone being with you that evening.

An EUS is a low-risk procedure in experienced hands, but it is still a procedure and it carries real risks. The recognised complications are inflammation of the pancreas afterwards, bleeding, a reaction to sedation, and, very uncommonly, a tear in the wall of the gut. Taking a needle sample carries slightly more risk than looking alone, which is one reason it is not done unless the answer will change something. These are uncommon events, and the endoscopy team will go through them with you and take written consent before you are sedated.

What matters more than the list is knowing which symptoms deserve a phone call rather than a wait-and-see. Contact the endoscopy centre, or go straight in, if any of the following appear in the hours or days afterwards.

• Severe or worsening abdominal pain, particularly pain boring through to the back that does not settle.
• Fever, shivering, or feeling generally unwell in the days after the procedure.
• Vomiting blood, or passing black tarry stool.
• Persistent vomiting, or being unable to keep fluids down.
• Chest pain, breathlessness, or new difficulty swallowing that does not ease.

This matters practically, because it decides where you travel and who invoices you. Endoscopic ultrasound and the EUS-FNA biopsy taken during it are coordinated with specialist gastroenterology, endoscopy and hepatobiliary partner centres, and may be billed there. The same is true of ERCP and any biliary or duodenal stenting, staging laparoscopy, a coeliac plexus block for pain, and all pancreatic surgery, from a Whipple operation to a distal pancreatectomy. PET-CT and receptor imaging are coordinated with partner nuclear-medicine centres. We would rather write that down here than let you discover it at a billing counter.

What happens at CION is everything around the procedure, and on a pancreatic pathway that is most of the journey. The decision on whether a biopsy is needed at all and by which route. Pancreatic-protocol CT, MRI and MRCP, CA 19-9 and routine bloods, ordered and reported by us. The tumour board that reads your pathology alongside your imaging. Chemotherapy before or after surgery and in advanced disease, maintenance treatment of the PARP-inhibitor class where a BRCA-type mutation is found, immune checkpoint treatment where mismatch-repair testing points to it, radiation, chemoradiation and SBRT — all delivered in-house across 35+ centres. Genetic counselling where the family history warrants it, nutrition and pancreatic enzyme support, pain and psycho-oncology care, and long-term follow-up.

• A free 45-minute consultation, with your scans opened and read in front of you rather than summarised back to you from a report.
• A straight answer on whether an EUS-FNA would change your management, and if it would not, we will say so instead of adding a procedure.
• A written split of what the partner endoscopy centre bills and what CION bills, before anything is booked.
• Aarogyasri, NTR Vaidya Seva and insurance routes checked against each part of the pathway, not only the treatment.
• The biopsy routes compared honestly in how a pancreatic biopsy is done, and the imaging explained in the pancreatic-protocol CT scan.
• The whole picture in one place, in our complete guide to pancreatic cancer.

Medical disclaimer: This page explains what an endoscopic ultrasound of the pancreas and an EUS-guided fine needle aspiration or biopsy involve, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not a substitute for an individual endoscopic, radiological or oncological opinion; whether this procedure is appropriate for you, and when, depends on your own imaging, symptoms and treatment plan and must be decided with your treating team. Pancreatic-protocol CT, MRI and MRCP, CA 19-9 and bloods, tumour-board planning, chemotherapy, maintenance and immunotherapy where testing supports them, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme support, pain and psycho-oncology care and survivorship follow-up are delivered by CION. Endoscopic ultrasound and EUS-guided biopsy, ERCP and biliary or duodenal stenting, staging laparoscopy, coeliac plexus block and all pancreatic surgery are coordinated with specialist gastroenterology, endoscopy and hepatobiliary partner centres, and PET-CT, DOTATATE PET-CT and PRRT with partner nuclear-medicine centres; each of these may be billed there.